U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864052) titled 'The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation' on Feb. 10.
Brief Summary: This study aims to determine whether there is a difference in brain lesion occurrence and safety when brain MRI is followed up between edoxaban and apixaban in stroke patients with nonvalvular atrial fibrillation through exploratory clinical trials.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Stroke
Atrial Fibrillation
Intervention:
DRUG: Administration of Apixaban
Apixaban 2.5mg BID or Apixaban 5mg BID
DRUG: Administration of Edo...